IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma John Verducci2023-06-15T18:31:47+00:00June 15, 2023|Publication| Risk or presence of metastasis in medulloblastoma causes substantial treatment-related morbidity and overall mortality. Read the full publication on PubMed. Share this story on social media. FacebookXLinkedInEmail
